To Be “Fit For 2018,” Merck Serono Hints At Earlier Stage Deals, But India May Have To Wait
This article was originally published in The Pink Sheet Daily
Executive Summary
The world’s oldest drug maker is gearing up to be a leaner machine by 2018, relying on studying data closely before signing deals.